![Jolyon Martin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jolyon Martin
Founder at PetMedix Ltd.
Network origin in Jolyon Martin first degree
Entity | Entity type | Industry | |
---|---|---|---|
PetMedix Ltd.
![]() PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom.
6
| Holding Company | Biotechnology | 6 |
Chessington Nurseries Ltd.
![]() Chessington Nurseries Ltd. Agricultural Commodities/MillingProcess Industries Chessington Nurseries Ltd. operates nursery farm. It offers gardening essentials, from seeds to tree, outdoor living, home, leisure, pets, and wildlife, aquatics, and design, build and maintenance services. The company was founded in 1949 and is headquartered in Chessington, the United Kingdom.
3
| Subsidiary | Agricultural Commodities/Milling | 3 |
Chessington Nurseries Holdings Co. Ltd.
![]() Chessington Nurseries Holdings Co. Ltd. Specialty StoresRetail Trade Chessington Nurseries Holdings Co. Ltd. is a retail company founded in 2017. The private company operates retail stores and is based in Chessington, UK. and has subsidiaries in United Kingdom.
2
| Private Company | Specialty Stores | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jolyon Martin via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Congenica Ltd.
![]() Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Founder Director/Board Member Chief Investment Officer | |
University of Cambridge | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Rejuvenate Bio, Inc.
![]() Rejuvenate Bio, Inc. BiotechnologyHealth Technology Rejuvenate Bio, Inc. operates as a biotechnology company. The company was founded by George Church, Noah Davidsohn and Daniel Oliver is headquartered in San Diego, CA. | Biotechnology | Consultant / Advisor | |
Predictimmune Ltd.
![]() Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
Albert Innovations Ltd. | Director/Board Member | ||
Victoria Innovations Ltd. | Director/Board Member | ||
Stonehaven Incubate AG
![]() Stonehaven Incubate AG Financial ConglomeratesFinance Stonehaven Incubate AG provides investment services in animal health sector. The company is headquartered in Andermatt, Switzerland. | Financial Conglomerates | Director/Board Member | |
SEQUENT SCIENTIFIC LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Iowa State University | College/University | Graduate Degree | |
Bessemer Investors
![]() Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
Novobind Livestock Therapeutics, Inc.
![]() Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | Biotechnology | Consultant / Advisor | |
The Royal Veterinary College | College/University | Consultant / Advisor | |
Wellcome Trust Sanger Institute
![]() Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PhoreMost Ltd.
![]() PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Consumer Health
![]() Novartis Consumer Health Medical/Nursing ServicesHealth Services Novartis Consumer Health engages in the provision of healthcare services. The company is headquartered in Swaziland. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Pfizer Animal Health
![]() Pfizer Animal Health Pharmaceuticals: MajorHealth Technology Part of Zoetis, Inc., Pfizer Animal Health engages in discovery, development and manufacture of innovative animal vaccines and medicines. The company is based in São Paulo, Brazil. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Business School | College/University | Graduate Degree | |
Novartis Animal Health US, Inc.
![]() Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Novartis Animal Health US, Inc. manufactures pharmaceutical products for animals. The company is based in Greensboro, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The University of Veterinary Medicine Hanover | College/University | Undergraduate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Digitalis Ventures LLC
![]() Digitalis Ventures LLC Investment ManagersFinance Digitalis Ventures LLC (Digitalis Ventures) is a venture capital firm founded in 2016 by Geoffrey W. Smith. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
University of Oxford | College/University | Graduate Degree | |
Bonum Therapeutics, Inc.
![]() Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bonum Therapeutics, Inc. is a privately held American company that focuses on generating a new class of therapeutics based on a proven technology platform. Bonum Therapeutics is based in an undisclosed location and was founded in 2022 by the Good Therapeutics team. The company's technology utilizes principles of allosteric regulation to create highly active and less toxic medicines, which can be applied to a wide range of therapeutic areas, including oncology, autoimmunity, metabolic disorders, and pain management. The company's molecules combine a sensor component directed against a specific biological marker and a therapeutic component. The company is backed by a group of leading venture investors, including Codon Capital, Roche Venture Fund, RiverVest Venture Partners, 3x5 Partners, Digitalis Ventures, and Vivo Capital. The company was founded by John Mulligan, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
EpiBiologics, Inc.
![]() EpiBiologics, Inc. Miscellaneous Commercial ServicesCommercial Services EpiBiologics, Inc. is an American biotech company that is developing a protein degradation platform to target membrane and extracellular proteins. The company is headquartered in an undisclosed location and is backed by leading healthcare investors. The company is based in San Francisco, CA. EpiBiologics' proprietary epitac platform is an antibody-based system that can precisely degrade disease-driving proteins in a tissue-specific manner. EpiBiologics aims to develop first-in-class and targeted therapies for cancer, immunology, and neurological diseases. The company was founded in 2022 by Dr. Jim Wells of the University of California, San Francisco (UCSF). Ann Lee-Karlon has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
Merial LLC | Chief Tech/Sci/R&D Officer | ||
Parkwalk Advisors Ltd.
![]() Parkwalk Advisors Ltd. Investment ManagersFinance Parkwalk Advisors Ltd. provides investment advisory services. The company was founded by Alastair Kilgour in 2009 and is headquartered in London, the United Kingdom. | Investment Managers | Founder | |
MIRRIAD ADVERTISING PLC | Advertising/Marketing Services | Director/Board Member | |
Sosei R&D Ltd.
![]() Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Kymab Group Ltd.
![]() Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
SOURCE BIOSCIENCE PLC | Medical/Nursing Services | Director/Board Member | |
University of Wisconsin | College/University | Doctorate Degree | |
Maxion Therapeutics Ltd.
![]() Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Vantia Ltd.
![]() Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
London Business School | College/University | Masters Business Admin | |
University College London | College/University | Undergraduate Degree | |
KalVista Pharmaceuticals Ltd.
![]() KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Avilex Pharma ApS
![]() Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
First Light Fusion Ltd.
![]() First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Cambridge Innovation Capital Ltd
![]() Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Private Equity Investor | |
Abcodia Ltd.
![]() Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Royal College of Obstetricians & Gynaecologists | College/University | Corporate Officer/Principal | |
Inivata Ltd.
![]() Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Director/Board Member | |
Morphogen-IX Ltd.
![]() Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
CMR Surgical Ltd.
![]() CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
Exvastat Ltd.
![]() Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Microbiotica Ltd.
![]() Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member |
Statistics
International
United Kingdom | 31 |
United States | 14 |
Switzerland | 2 |
India | 2 |
Canada | 2 |
Sectoral
Health Technology | 21 |
Consumer Services | 12 |
Commercial Services | 7 |
Finance | 6 |
Health Services | 3 |
Operational
Director/Board Member | 35 |
Chief Tech/Sci/R&D Officer | 8 |
Corporate Officer/Principal | 6 |
Founder | 6 |
Graduate Degree | 5 |
Most connected contacts
- Stock Market
- Insiders
- Jolyon Martin
- Company connections